CA
NZ
UK
AU
IND
US
Cencora (NYSE:COR) slipped on Friday, landing among the S&P 500's weaker stocks on a day when health care was the only one of 11 sectors to close lower. The drug wholesaler, formerly known as AmerisourceBergen, distributes branded and generic medicines to pharmacies, hospitals and …
Alnylam Pharmaceuticals (NASDAQ:ALNY) slipped on Friday, finishing among the weaker stocks on the Nasdaq-100 even as the index closed at a record high. Alnylam is a pioneer of RNA interference, a type of medicine that silences disease-causing genes, with approved drugs for rare and …
Amgen (NASDAQ:AMGN) shares slipped on Friday, October 2, as biotech stocks joined the broader health-care sector in sitting out a tech-led market rally. No company-specific news was found for Amgen. The California-based biotech, known for medicines in areas such as bone health, cardiovascular disease …
McKesson (NYSE:MCK) handed back some of Thursday's gains on Friday, with no fresh news and health care lagging a market that was busy chasing chips. Shares slipped onto the list of the S&P 500's weaker stocks one day after a strong rally on a …
Veeva Systems (NYSE:VEEV) sells cloud software built specifically for the life sciences industry. Drugmakers and biotech firms use its tools to manage clinical trials, regulatory filings, quality records and sales andMarketingto doctors. That makes it a technology company whose fortunes are tied closely to …
Welireg is an oral inhibitor of hypoxia-inducibleFactor2 alpha, and Lenvima is a tyrosine kinase inhibitor, so the combination attacks two pathways in advanced renal cell carcinoma, the most common kidney cancer. The approval came on its October 4 target date, which indicates an orderly …
Merck & Co., Inc. (NYSE:MRK) gained clearance for Welireg, an oral inhibitor of hypoxia-inducibleFactor2 alpha, in combination with Lenvima for advanced renal cell carcinoma, the most common type of kidney cancer. The decision came on its October 4 target date. Edwards Lifesciences Corporation (NYSE:EW) …
Allergy Therapeutics develops, manufactures and sells allergy immunotherapy treatments, which aim to address the underlying cause of allergies rather than just the symptoms. Its registered product portfolio includes Pollinex and Venomil, and it is advancing a pipeline of next-generation treatments, including VLP Peanut. Germany …
Smith & Nephew is a medical technology company listed in London and, through American depositary shares, in New York. It reports threeBusinessunits: Orthopaedics, which includes hip and knee implants; Sports Medicine and ENT; and Advanced Wound Management. The company says it employs about 17,000 …
hVIVO is an AIM-quoted clinical trials services company. It runs aQuarantineFacilityin Canary Wharf, London, which it describes as the largest of its kind worldwide, for human challenge trials. It also operates CRS clinical sites in Mannheim and Kiel in Germany, which carry out early-phase …
Please wait processing your request...